BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc. ("Cosette") announced that the U.S. Food and Drug Administration (FDA) has approved the Abbreviated New Drug Applications (ANDA) for ...
Actavis and Valeant announced that the FDA has approved Metronidazole 1.3% Vaginal Gel for the treatment of bacterial vaginosis. In April 2013, Actavis acquired the rights to Metronidazole 1.3% from ...
DUBLIN and LAVAL, Quebec, March 25, 2014 /CNW/ - Actavis plc (NYSE: ACT) and Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that the U.S. Food and Drug ...
Participants with recurrent bacterial vaginosis demonstrated a significantly higher treatment response to oral metronidazole than to intravaginal lactic acid gel at 2 weeks, but treatment failure was ...
METROGEL (metronidazole) 1% gel pump by Galderma Galderma announced that MetroGel 1% (metronidazole) will now be supplied in a pump bottle. Galderma announced that MetroGel 1% (metronidazole) will now ...
Medindia updates the prices regularly, however, there may be slight discrepancies in the prices displayed. This can be due to the following reasons:Medindia updates the prices regularly, however, ...
The Directorate General of Foreign Trade (DGFT) has notified a new Standard Input Output Norm (SION) for metronidazole gel under the chemical & allied product category. This development comes as part ...
Metronidazole is a generic prescription drug that’s used to treat certain types of infections. Metronidazole is also available as the brand-name drugs Flagyl, MetroCream, and many others. This article ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Actavis and Valeant Pharmaceuticals International Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results